Propofol attenuates the decrease of dynamic compliance and water content in the lung by decreasing oxidative radicals...

Area of Science:

• Hepatology
• Pulmonology
• Anesthesiology

Background:

• Remote pulmonary injuries post-hepatic reperfusion are often linked to reactive oxygen species (ROS).
• Anesthetic choice influences oxidant-antioxidant balance; propofol exhibits antioxidant properties.
• This study investigates propofol's effect on hepatic ischemia/reperfusion (I/R)-induced lung dysfunction.

Purpose of the Study:

• To establish a rat model for studying pulmonary function during hepatic I/R.
• To determine if propofol attenuates remote pulmonary dysfunction.
• To investigate propofol's mechanism, specifically its impact on ROS production in the liver and lungs.

Main Methods:

• Adult male rats were allocated to sham or hepatic I/R groups, receiving either pentobarbital or propofol anesthesia.
• Hepatic I/R was induced by clamping the portal vein and hepatic artery.
• Pulmonary function assessed via dynamic compliance, resistance, wet-to-dry ratio, and histopathology; ROS and lipid peroxidation products measured.

Main Results:

• Hepatic I/R induced lung injury, evidenced by decreased dynamic compliance and increased resistance/wet-to-dry ratio.
• ROS production significantly increased post-I/R, particularly in the inferior vena cava.
• Propofol administration significantly attenuated I/R-induced lung injury and liver damage compared to pentobarbital, correlating with reduced ROS.

Conclusions:

• The rat model successfully demonstrated remote pulmonary dysfunction and liver reperfusion injury.
• Massive ROS production and lipid peroxidation were key contributors to the observed injuries.
• Propofol infusion effectively lessened oxidative stress from the reperfused liver, thereby attenuating remote pulmonary injury.